A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

April 21, 2021

Study Completion Date

July 13, 2021

Conditions

Pharmacokinetics

Interventions

DRUG

Kava Dietary Supplement

Participants will be given three 75mg kava capsules.

Trial Locations (1)

UF CTSI Clinical Research Center, Gainesville

All Listed Sponsors

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Thorne HealthTech, Inc

INDUSTRY

lead

University of Florida

OTHER

NCT03843502 - A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics | Biotech Hunter | Biotech Hunter